CashuAstex Pharmaceuticals Inc.: Innovating Biotech with Fragment-Based Drug Design and Strategic Partnerships6 months ago
CashuAstex Pharmaceuticals Inc: Pioneering Innovative Drug Development in Oncology and Hematology6 months ago
CashuAstex Pharmaceuticals Inc. Leverages AI Innovations for Drug Discovery and Competitive Advantage6 months ago
prnewswire.comOptions Trading Now Available on Latest Five Tradr ETFs: CWVX, SMU, ASTX, GEVX and CEGX6 months ago
finance.yahoo.comAstex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposiumabout 1 year ago
finance.yahoo.comNovartis Kisqali shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancerover 1 year ago
businesswire.comOpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQover 1 year ago
businesswire.comElectra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr. Kim-Hien Dao as Chief Medical Officerover 1 year ago
finance.yahoo.comNovartis highlights pioneering innovation in CML with data from Scemblix Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHAover 1 year ago
finance.yahoo.comSmall Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trialsover 1 year ago
finance.yahoo.comPheochromocytoma Pipeline Insight Report 2024, Featuring Genentech, Exelixis, Advanced Accelerator Applications, Enterome, FUJIFILM Toyama Chemical, Ipsen, Pfizer and Astex Pharmaceuticalsalmost 2 years ago
benzinga.comAstex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meetingalmost 2 years ago